Effects of Paclitaxel on Plasma Membrane Microviscosity and Lipid Composition in Cancer Cells

• Published in: International journal of molecular sciences 2023-07, Vol.24 (15), p.12186
• Main Authors: Shimolina, Liubov, Gulin, Alexander, Khlynova, Alexandra, Ignatova, Nadezhda, Druzhkova, Irina, Gubina, Margarita, Zagaynova, Elena, Kuimova, Marina K, Shirmanova, Marina
• Format: Article
• Language: English
• Subjects: Apoptosis; Cancer; cancer cells; Cancer therapies; Cell membranes; Cells; Chemotherapy; Drug dosages; Fatty acids; FLIM microscopy; Fluorescence microscopy; Ions; Lipids; Mass spectrometry; mass spectrometry ToF-SIMS; Membranes; microviscosity; molecular rotor; Morphology; Paclitaxel; Plasma; plasma membrane; Spheroids; Tumors; Viscosity
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241512186

The cell membrane is an important regulator for the cytotoxicity of chemotherapeutic agents. However, the biochemical and biophysical effects that occur in the membrane under the action of chemotherapy drugs are not fully described. In the present study, changes in the microviscosity of membranes of living HeLa-Kyoto tumor cells were studied during chemotherapy with paclitaxel, a widely used antimicrotubule agent. To visualize the microviscosity of the membranes, fluorescence lifetime imaging microscopy (FLIM) with a BODIPY 2 fluorescent molecular rotor was used. The lipid profile of the membranes was assessed using time-of-flight secondary ion mass spectrometry ToF-SIMS. A significant, steady-state decrease in the microviscosity of membranes, both in cell monolayers and in tumor spheroids, was revealed after the treatment. Mass spectrometry showed an increase in the unsaturated fatty acid content in treated cell membranes, which may explain, at least partially, their low microviscosity. These results indicate the involvement of membrane microviscosity in the response of tumor cells to paclitaxel treatment.